Regent Pacific Group together with its subsidiaries, a specialist healthcare, wellness and life sciences investment group, and its commercial partners have pioneered and originated various creative, innovative and technological assets including Fortacin™ product (approved by the European Medicines Agency (EMA) on 15 Nov 2013).
We are the owner and / or authorised users of all intellectual property rights including patents, copyright, trademarks, business names, rights in get-up and trade dress, goodwill and reputation, right to sue for passing off or unfair competition, rights in designs, database rights, righters to use and protect the confidentiality of, confidential information (covering know-how and trade secrets) and all other intellectual property rights, in all cases whether registered or unregistered, and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any countries/ regions concerned, all regarding Fortacin™ product, the well-known trademarks "FORTACIN", "SENSTEND" and a portfolio of other marks.
In collaboration with our commercial partners, we are commercialising Fortacin™ product around the world and more specifically in Mainland China, where we use the trademark and marketing name Senstend™ instead of Fortacin™. At present, we have not used and are not using the FORTACIN trademark in Mainland China. The trademarks Fortacin™ / Senstend™ are being used only in the respective jurisdictions where we (by ourselves and through our commercial partners) have obtained valid trademark registration for the mark concerned.
Deep Longevity Limited is the owner / or authorized users of all intellectual property rights including patents, copyright, business names, rights in get-up and trade dress, goodwill and reputation, right to sue for passing off or unfair competition, rights in designs, database rights, righters to use and protect the confidentiality of, confidential information (covering know-how and trade secrets) and all other intellectual property rights, in all cases whether registered or unregistered and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any countries/ regions concerned, all regarding the methods of creating and applying Deep Aging Clocks and a portfolio of other marks.